Drugs / Hollow gold and silver alloy cuprous oxide shell nano-shell hydrogel
Hollow gold and silver alloy cuprous oxide shell nano-shell hydrogel
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT05268718 | Aug 2021 → Dec 2023 | corneal ulcer | Second Affiliated Hospital, School of Medicine, Zhejiang University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hollow gold and silver alloy cuprous oxide shell nano-shell hydrogel | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05268718 ↗ |
| Route | Topical | “the eyes were coated with Au-Ag-Cu2O nano-gel once” NCT05268718 ↗ |